Literature DB >> 9607540

Effect of the introduction of total mesorectal excision for the treatment of rectal cancer.

E Carlsen1, E Schlichting, I Guldvog, E Johnson, R J Heald.   

Abstract

BACKGROUND: Total mesorectal excision (TME) has been reported to reduce local recurrence and improve survival rates in patients with rectal carcinoma. This paper reports the problems that have arisen with the introduction of this new surgical technique.
METHODS: This was a prospective study of two consecutive groups of patients: one who underwent TME (n = 76) and one who did not (non-TME, n = 76).
RESULTS: Postoperative mortality rate in the non-TME and TME group was 5 and 7 per cent respectively, and the rate of anastomotic failure was 8 and 16 per cent respectively. Anastomotic leaks in TME patients were located in the mid and lower rectum. TME patients with anastomotic failure had lower anastomoses and a longer duration of operation than non-TME patients. Intraoperative problems were encountered in 71 per cent of the failures. All TME patients who had a leak required reoperation compared with 25 per cent of non-TME patients. TME patients without postoperative complications stayed significantly longer in hospital than non-TME patients.
CONCLUSION: Anastomotic dehiscence increased after introduction of the TME technique but this improved with experience.

Entities:  

Mesh:

Year:  1998        PMID: 9607540     DOI: 10.1046/j.1365-2168.1998.00601.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  77 in total

1.  The management of leaking rectal anastomoses by minimally invasive techniques.

Authors:  M Pera; S Delgado; J C García-Valdecasas; M Pera; A Castells; J M Piqué; E Bombuy; A M Lacy
Journal:  Surg Endosc       Date:  2001-12-10       Impact factor: 4.584

Review 2.  Optimising treatment for resectable rectal cancer: is preoperative therapy beneficial?

Authors:  S Y Ngan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Total mesorectal excision for rectal cancer: the truth lies underneath.

Authors:  Jesús A Fernández-Represa; Julio M Mayol; Julio Garcia-Aguilar
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

Review 4.  Total mesorectal excision: technical aspects.

Authors:  P Terry Phang
Journal:  Can J Surg       Date:  2004-04       Impact factor: 2.089

5.  Is laparoscopic colorectal cancer surgery equal to open surgery? An evidence based perspective.

Authors:  Beat M Künzli; Helmut Friess; Shailesh V Shrikhande
Journal:  World J Gastrointest Surg       Date:  2010-04-27

6.  To drain or not to drain.

Authors:  Susan Galandiuk
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

7.  Intraoperative radiotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Five consecutive case reports of locally advanced rectal cancer with synchronous peritoneal carcinomatosis.

Authors:  Y L B Klaver; V E P P Lemmens; S W Nienhuijs; G A P Nieuwenhuijzen; H J T Rutten; I H J T de Hingh
Journal:  Strahlenther Onkol       Date:  2013-01-19       Impact factor: 3.621

8.  Male sexual and urinary function after laparoscopic total mesorectal excision.

Authors:  Mario Morino; Umberto Parini; Marco Ettore Allaix; Gabriella Monasterolo; Riccardo Brachet Contul; Corrado Garrone
Journal:  Surg Endosc       Date:  2008-10-15       Impact factor: 4.584

9.  Prophylactic transanal decompression tube versus non-prophylactic transanal decompression tube for anastomotic leakage prevention in low anterior resection for rectal cancer: a meta-analysis.

Authors:  Yun Yang; Ye Shu; Fangyu Su; Lin Xia; Baofeng Duan; Xiaoting Wu
Journal:  Surg Endosc       Date:  2016-09-12       Impact factor: 4.584

10.  Laparoscopic rectal surgery for middle and lower rectal cancer.

Authors:  Yosuke Fukunaga; Masayuki Higashino; Shinnya Tanimura; Masashi Takemura; Yushi Fujiwara
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.